Daniel O. Claassen

7.8k total citations · 2 hit papers
198 papers, 4.7k citations indexed

About

Daniel O. Claassen is a scholar working on Neurology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Daniel O. Claassen has authored 198 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Neurology, 89 papers in Cellular and Molecular Neuroscience and 38 papers in Cognitive Neuroscience. Recurrent topics in Daniel O. Claassen's work include Neurological disorders and treatments (71 papers), Parkinson's Disease Mechanisms and Treatments (67 papers) and Genetic Neurodegenerative Diseases (60 papers). Daniel O. Claassen is often cited by papers focused on Neurological disorders and treatments (71 papers), Parkinson's Disease Mechanisms and Treatments (67 papers) and Genetic Neurodegenerative Diseases (60 papers). Daniel O. Claassen collaborates with scholars based in United States, Netherlands and United Kingdom. Daniel O. Claassen's co-authors include Alejandro A. Rabinstein, Jennifer E. Fugate, Osman Kozak, Harry J. Cloft, David F. Kallmes, Scott A. Wylie, Eelco F. M. Wijdicks, Manus J. Donahue, Daniel Weintraub and Keith A. Josephs and has published in prestigious journals such as New England Journal of Medicine, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Daniel O. Claassen

182 papers receiving 4.6k citations

Hit Papers

Posterior Reversible Encephalopathy Syndrome: Associated ... 2010 2026 2015 2020 2010 2024 200 400 600

Peers

Daniel O. Claassen
Daniel O. Claassen
Citations per year, relative to Daniel O. Claassen Daniel O. Claassen (= 1×) peers Jianguo Zhang

Countries citing papers authored by Daniel O. Claassen

Since Specialization
Citations

This map shows the geographic impact of Daniel O. Claassen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel O. Claassen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel O. Claassen more than expected).

Fields of papers citing papers by Daniel O. Claassen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel O. Claassen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel O. Claassen. The network helps show where Daniel O. Claassen may publish in the future.

Co-authorship network of co-authors of Daniel O. Claassen

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel O. Claassen. A scholar is included among the top collaborators of Daniel O. Claassen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel O. Claassen. Daniel O. Claassen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Considine, Ciaran, Clare M. Eddy, Samuel Frank, et al.. (2025). Improving the Clinical Diagnostic Criteria for Genetically Confirmed Adult-Onset Huntington Disease. Neurology Clinical Practice. 15(2). e200427–e200427. 2 indexed citations
2.
3.
Stimming, Erin Furr, Daniel O. Claassen, Elise Kayson, et al.. (2024). Sustained Improvements in Chorea Associated with Huntington Disease with Once-Daily Valbenazine: Interim Results from a Long-Term Open-Label Study. CNS Spectrums. 29(5). 513–514. 1 indexed citations
4.
Rezai, Ali R., Pierre-François D’Haese, Jeffrey Carpenter, et al.. (2024). Ultrasound Blood–Brain Barrier Opening and Aducanumab in Alzheimer’s Disease. New England Journal of Medicine. 390(1). 55–62. 150 indexed citations breakdown →
5.
Guzauskas, Gregory F., Sarah J. Tabrizi, Jeffrey D. Long, et al.. (2024). Long-Term Health Outcomes of Huntington Disease and the Impact of Future Disease-Modifying Treatments. Neurology Clinical Practice. 14(5). e200340–e200340.
6.
Claassen, Daniel O., et al.. (2023). Mesial temporal dopamine: From biology to behaviour. European Journal of Neuroscience. 59(6). 1141–1152. 4 indexed citations
7.
Watson, Kelly H., et al.. (2023). Intrapersonal and Interpersonal Disengagement Coping: Associations with Emotions of Youth At-Risk for Huntington’s Disease. Journal of Huntington s Disease. 12(3). 305–312. 2 indexed citations
8.
Hett, Kilian, et al.. (2023). Cerebrospinal Fluid Flow in Patients with Huntington's Disease. Annals of Neurology. 94(5). 885–894. 2 indexed citations
9.
Lin, Chi‐Ying, et al.. (2022). Cerebellar impulsivity–compulsivity assessment scale. Annals of Clinical and Translational Neurology. 10(1). 48–57. 4 indexed citations
10.
Diehl, Sarah, Michael de Riesthal, Kris Tjaden, et al.. (2022). Dysarthria Subgroups in Talkers with Huntington’s Disease: Comparison of Two Data-Driven Classification Approaches. Brain Sciences. 12(4). 492–492. 3 indexed citations
11.
Lin, Chi‐Ying, et al.. (2022). Impulsivity Trait Profiles in Patients With Cerebellar Ataxia and Parkinson Disease. Neurology. 99(2). e176–e186. 11 indexed citations
13.
Watson, Kelly H., et al.. (2021). Neurobiological and Psychosocial Correlates of Communication Between Huntington’s Disease Patients and Their Offspring. Journal of Neuropsychiatry. 33(4). 321–327. 3 indexed citations
14.
15.
Key, Alexandra P., Carissa J. Cascio, Alexander C. Conley, et al.. (2020). <p>Sensory Hypersensitivity Severity and Association with Obsessive-Compulsive Symptoms in Adults with Tic Disorder</p>. Neuropsychiatric Disease and Treatment. Volume 16. 2591–2601. 14 indexed citations
16.
Stark, Adam, Christopher T. Smith, Kalen J. Petersen, et al.. (2018). [18F]fallypride characterization of striatal and extrastriatal D2/3 receptors in Parkinson's disease. NeuroImage Clinical. 18. 433–442. 26 indexed citations
17.
Bissett, Patrick G., Gordon D. Logan, Nelleke C. van Wouwe, et al.. (2015). Generalized motor inhibitory deficit in Parkinson’s disease patients who freeze. Journal of Neural Transmission. 122(12). 1693–1701. 18 indexed citations
18.
Claassen, Daniel O., et al.. (2014). Parkinson's Disease Motor Phenotype Predicts Cognitive Performance (P5.264). Neurology. 82(10_supplement). 1 indexed citations
19.
Claassen, Daniel O., Wery P. M. van den Wildenberg, Madaline B. Harrison, et al.. (2014). Proficient motor impulse control in Parkinson disease patients with impulsive and compulsive behaviors. Pharmacology Biochemistry and Behavior. 129. 19–25. 41 indexed citations
20.
Bergman, Ira, David N. Finegold, J. Carlton Gartner, et al.. (1989). Acute Profound Dystonia in Infants With Glutaric Acidemia. PEDIATRICS. 83(2). 228–234. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026